$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000149229813000022 Filed on May 06, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$32.02M	$23.73M
YoY Change	34.96%	34.8%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.700M	$4.300M
YoY Change	9.3%	59.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.246M	$7.303M
YoY Change	12.91%	20.0%
% of Gross Profit
Operating Expenses	$12.50M	$11.60M
YoY Change	7.76%	31.82%
Operating Profit
YoY Change
Interest Expense	-$10.00M	-$7.700M
YoY Change	29.87%	1.32%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$9.600M	$4.400M
YoY Change	118.18%	266.67%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%
Net Earnings	$9.557M	$4.405M
YoY Change	116.96%	252.96%
Net Earnings / Revenue	29.85%	18.57%
Basic Earnings Per Share	$0.25	$0.12
Diluted Earnings Per Share	$0.25	$0.12
COMMON SHARES
Basic Shares Outstanding	37.29M shares	37.04M shares
Diluted Shares Outstanding	37.74M shares	37.06M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.60M	$2.700M
YoY Change	1885.19%	-96.63%
Cash & Equivalents	$53.57M	$2.675M
Short-Term Investments
Other Short-Term Assets	$37.50M	$31.00M
YoY Change	20.97%	84.52%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$91.10M	$33.70M
YoY Change	170.33%	-94.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$819.0M	$680.6M
YoY Change	20.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$29.50M	$32.20M
YoY Change	-8.39%	1.26%
Total Long-Term Assets	$873.5M	$712.8M
YoY Change	22.53%	2134.62%
TOTAL ASSETS
Total Short-Term Assets	$91.10M	$33.70M
Total Long-Term Assets	$873.5M	$712.8M
Total Assets	$964.6M	$746.5M
YoY Change	29.2%	23.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.40M	$17.80M
YoY Change	3.37%	34.85%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$42.60M	$43.30M
YoY Change	-1.62%	9.62%
LONG-TERM LIABILITIES
Long-Term Debt	$481.8M	$382.6M
YoY Change	25.93%	-0.8%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$481.8M	$382.6M
YoY Change	25.93%	-0.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$42.60M	$43.30M
Total Long-Term Liabilities	$481.8M	$382.6M
Total Liabilities	$524.4M	$425.9M
YoY Change	23.12%	0.2%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$373.0K	$370.0K
YoY Change	0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$440.1M	$320.6M
YoY Change
Total Liabilities & Shareholders Equity	$964.6M	$746.5M
YoY Change	29.2%	23.38%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	$9.557M	$4.405M
YoY Change	116.96%	252.96%
Depreciation, Depletion And Amortization	$8.246M	$7.303M
YoY Change	12.91%	20.0%
Cash From Operating Activities	$21.60M	$16.46M
YoY Change	31.21%	32.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$15.30M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$15.31M	-$40.21M
YoY Change	-61.92%	642.55%
FINANCING ACTIVITIES
Cash Dividend Paid	$12.72M	$12.21M
YoY Change	4.12%
Common Stock Issuance & Retirement, Net	-$2.534M	-$370.0K
YoY Change	584.86%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$30.17M	-$15.83M
YoY Change	-290.6%	1384.99%
NET CHANGE
Cash From Operating Activities	$21.60M	$16.46M
Cash From Investing Activities	-$15.31M	-$40.21M
Cash From Financing Activities	$30.17M	-$15.83M
Net Change In Cash	$36.46M	-$39.58M
YoY Change	-192.14%	-762.12%
FREE CASH FLOW
Cash From Operating Activities	$21.60M	$16.46M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-4000	USD
CY2012Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	566000	USD
CY2013Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	766000	USD
CY2012Q4	us-gaap	Assets Assets	916882000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11694000	USD
CY2013Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	18414000	USD
CY2012Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	48744000	USD
CY2013Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	52302000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	353861000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	492011000	USD
CY2012Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2203000	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2569000	USD
CY2013Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2013Q1	us-gaap	Assets Assets	964566000	USD
CY2013Q1	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	0	USD
CY2012Q4	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	2215000	USD
CY2013Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	782221000	USD
CY2012Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	782221000	USD
CY2013Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability	500000	USD
CY2012Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability	0	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53565000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17101000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2675000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42250000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42250000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	36464000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-39575000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.34
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.34
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37099209	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37333943	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37099209	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37333943	shares
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	373000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	371000	USD
CY2013Q1	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	1.7864
CY2013Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24212000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24212000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8246000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7303000	USD
CY2012Q1	us-gaap	Dividends Common Stock DividendsCommonStock	-12213000	USD
CY2013Q1	us-gaap	Dividends Common Stock DividendsCommonStock	-12811000	USD
CY2013Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	304000	USD
CY2012Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2013Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	304000	USD
CY2013Q1	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2012Q4	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2013Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2012Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2012Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	43810000	USD
CY2013Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	43810000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4321000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4717000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4053000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6513000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	126000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	513000	USD
CY2012Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	967000	USD
CY2012Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	22916	shares
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	1063000	USD
CY2013Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	453843	shares
CY2012Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7698000	USD
CY2013Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	10002000	USD
CY2013Q1	us-gaap	Interest Paid InterestPaid	3064000	USD
CY2012Q1	us-gaap	Interest Paid InterestPaid	2140000	USD
CY2012Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	5400000	USD
CY2013Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	11800000	USD
CY2013Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2012Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2012Q4	us-gaap	Land Land	126048000	USD
CY2013Q1	us-gaap	Land Land	126048000	USD
CY2013Q1	us-gaap	Land Improvements LandImprovements	4535000	USD
CY2012Q4	us-gaap	Land Improvements LandImprovements	4535000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	524426000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	611394000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	916882000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	964566000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	0	USD
CY2012Q4	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	92500000	USD
CY2013Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	24857000	USD
CY2013Q1	us-gaap	Loans Receivable Net LoansReceivableNet	24978000	USD
CY2012Q4	us-gaap	Loans Receivable Net LoansReceivableNet	12017000	USD
CY2013Q1	us-gaap	Long Term Debt LongTermDebt	476333000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	378340000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2230000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2138000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	86522000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4146000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	2957000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15830000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30172000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15311000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40209000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16464000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21603000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	4405000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	9557000	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4405000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9253000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	1368662000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	83939000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	123411000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	120445000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	117578000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	114834000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	808455000	USD
CY2013Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	31475000	USD
CY2012Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	23663000	USD
CY2012Q1	us-gaap	Other Income OtherIncome	0	USD
CY2013Q1	us-gaap	Other Income OtherIncome	500000	USD
CY2013Q1	us-gaap	Other Noncash Income OtherNoncashIncome	-5000	USD
CY2012Q1	us-gaap	Other Noncash Income OtherNoncashIncome	0	USD
CY2012Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2012Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12213000	USD
CY2013Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12716000	USD
CY2012Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2456000	USD
CY2013Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	72000	USD
CY2013Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	0	USD
CY2012Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	256000	USD
CY2013Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4646000	USD
CY2012Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2013Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	12873000	USD
CY2012Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	10103000	USD
CY2012Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	10103000	USD
CY2012Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	29850000	USD
CY2013Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2013Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.07125
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	25.00
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5750000	shares
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	58000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2012Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-2534000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-370000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	138983000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	138400000	USD
CY2013Q1	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	-12873000	USD
CY2012Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2013Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	0	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	2208000	USD
CY2012Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	129479000	USD
CY2013Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	137588000	USD
CY2013Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	956614000	USD
CY2012Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	956614000	USD
CY2012Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	827135000	USD
CY2013Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	819026000	USD
CY2013Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	92500000	USD
CY2012Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2013Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	989000	USD
CY2012Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	791000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4589000	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5278000	USD
CY2013Q1	us-gaap	Revenues Revenues	32022000	USD
CY2012Q1	us-gaap	Revenues Revenues	23727000	USD
CY2012Q4	us-gaap	Secured Debt SecuredDebt	152322000	USD
CY2013Q1	us-gaap	Secured Debt SecuredDebt	151333000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2474000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2203000	USD
CY2013Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	800000	shares
CY2012Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-370000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	305488000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	440140000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	326573000	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	320598000	USD
CY2012Q1	us-gaap	Straight Line Rent StraightLineRent	969000	USD
CY2013Q1	us-gaap	Straight Line Rent StraightLineRent	3683000	USD
CY2012Q4	us-gaap	Unsecured Debt UnsecuredDebt	330666000	USD
CY2013Q1	us-gaap	Unsecured Debt UnsecuredDebt	330467000	USD
CY2013Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></div></div>
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37739964	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37058886	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37035970	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37286121	shares
CY2013Q1	sbra	Amortization Of Premium On Senior Unsecured Notes AmortizationOfPremiumOnSeniorUnsecuredNotes	-199000	USD
CY2012Q1	sbra	Amortization Of Premium On Senior Unsecured Notes AmortizationOfPremiumOnSeniorUnsecuredNotes	0	USD
CY2013Q1	sbra	Common Stock At Market Stock Offering Max Possible Gross Proceeds CommonStockAtMarketStockOfferingMaxPossibleGrossProceeds	100000000	USD
CY2013Q1	sbra	Common Stock At Market Stock Offering Number Of Shares Sold CommonStockAtMarketStockOfferingNumberOfSharesSold	0	shares
CY2013Q1	sbra	Common Stock At Market Stock Offering Sales Commision CommonStockAtMarketStockOfferingSalesCommision	0.02
CY2012Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2013Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2013Q1	sbra	Interest Income InterestIncome	547000	USD
CY2012Q1	sbra	Interest Income InterestIncome	64000	USD
CY2013Q1	sbra	Liability For Uncertain Tax Positions LiabilityForUncertainTaxPositions	24212000	USD
CY2012Q4	sbra	Liability For Uncertain Tax Positions LiabilityForUncertainTaxPositions	24212000	USD
CY2013Q1	sbra	Loan Receivable Face Value LoanReceivableFaceValue	24857000	USD
CY2012Q4	sbra	Loan Receivable Face Value LoanReceivableFaceValue	11965000	USD
CY2013Q1	sbra	Loans And Leases Receiavble Effective Interest Rate LoansAndLeasesReceiavbleEffectiveInterestRate	0.0868131404
CY2013Q1	sbra	Loans And Leases Receivable Fixed Interest Rate LoansAndLeasesReceivableFixedInterestRate	0.0877873436
CY2013Q1	sbra	Loans And Leases Receivable Number Of Loans LoansAndLeasesReceivableNumberOfLoans	3
CY2013Q1	sbra	Operating Leases Weighted Average Lease Expiration Period OperatingLeasesWeightedAverageLeaseExpirationPeriod	P11Y
CY2012Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2013Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2012Q1	sbra	Payments Of Distributions To Parent PaymentsOfDistributionsToParent	0	USD
CY2013Q1	sbra	Payments Of Distributions To Parent PaymentsOfDistributionsToParent	0	USD
CY2013Q1	sbra	Preferred Equity Investments Number PreferredEquityInvestmentsNumber	2	Facilities
CY2012Q4	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	29613000	USD
CY2013Q1	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	37507000	USD
CY2012Q1	sbra	Proceeds From Distributions To Parent Investing Activities ProceedsFromDistributionsToParentInvestingActivities	0	USD
CY2013Q1	sbra	Proceeds From Distributions To Parent Investing Activities ProceedsFromDistributionsToParentInvestingActivities	0	USD
CY2013Q1	sbra	Total Expenses TotalExpenses	22965000	USD
CY2012Q1	sbra	Total Expenses TotalExpenses	19322000	USD
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37333943	shares
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	Sabra Health Care REIT, Inc.

Files In Submission

Name	View Source	Status
0001492298-13-000022-index-headers.html	Edgar Link	pending
0001492298-13-000022-index.html	Edgar Link	pending
0001492298-13-000022.txt	Edgar Link	pending
0001492298-13-000022-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20130331.xml	Edgar Link	completed
sbra-20130331.xsd	Edgar Link	pending
sbra-20130331_cal.xml	Edgar Link	unprocessable
sbra-20130331_def.xml	Edgar Link	unprocessable
sbra-20130331_lab.xml	Edgar Link	unprocessable
sbra-20130331_pre.xml	Edgar Link	unprocessable
sbra10q2013q1.htm	Edgar Link	pending
sbraex1212013q1.htm	Edgar Link	pending
sbraex3112013q1.htm	Edgar Link	pending
sbraex3122013q1.htm	Edgar Link	pending
sbraex3212013q1.htm	Edgar Link	pending
sbraex3222013q1.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2013 Q1 Form 10-Q Financial Statement

#000149229813000022 Filed on May 06, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2013 Q1 Form 10-Q Financial Statement

#000149229813000022 Filed on May 06, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra